Raffaelina Mercogliano | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Raffaelina Mercogliano
Affiliation Università Federico II di Napoli
Country Italy
Scopus ID 24830941800
Documents 52
Citations 1,376 citations by 1,259 documents
h-index 22
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9167-4091

Raffaelina Mercogliano
Università Federico II di Napoli (Italy)

The Innovative Research Award profile recognizes the scholarly achievements and scientific contributions of Raffaelina Mercogliano, a researcher associated with Università Federico II di Napoli, Italy. Her academic portfolio reflects sustained contributions to medicine and health sciences, with a publication record demonstrating interdisciplinary engagement, research visibility, and measurable scientific impact. The recognition is presented within the framework of the International Forensic Scientist Awards and highlights excellence in research productivity, citation influence, and academic leadership.[1][2]

Abstract

This academic recognition profile summarizes the research accomplishments, publication activity, and scholarly influence of Raffaelina Mercogliano. The profile examines research productivity, citation performance, and disciplinary contributions within medicine and health sciences. Available bibliometric indicators suggest a sustained record of scientific engagement and international visibility, supporting consideration for recognition through the Innovative Research Award.[1][3]

Keywords

Innovative Research Award, Raffaelina Mercogliano, Medicine and Health Sciences, Scientific Recognition, Research Excellence, Citation Impact, Academic Achievement, Scholarly Publications, Health Research, International Forensic Scientist Awards.

Introduction

Academic awards play an important role in recognizing the contributions of researchers whose work advances scientific knowledge and professional practice. Evaluation criteria frequently include publication output, citation influence, research quality, and engagement with emerging scientific challenges. Within this context, the profile of Raffaelina Mercogliano reflects a research trajectory characterized by scholarly productivity and measurable impact within medicine and health sciences.[2][4]

Research Profile

Raffaelina Mercogliano is affiliated with Università Federico II di Napoli, one of Italy’s established research institutions. Her scholarly record includes 52 indexed documents and an h-index of 22, reflecting both productivity and sustained citation activity. The available citation metrics indicate broad engagement with her research findings across multiple publications and scientific communities.[1][2]

Research Contributions

The research contributions associated with this profile demonstrate engagement with topics relevant to medicine, health sciences, food safety, public health, and related interdisciplinary domains. Such work contributes to evidence-based practices, scientific understanding, and methodological advancement. The cumulative impact of these contributions is reflected through extensive scholarly citations and continued relevance within the academic literature.[3][5]

Publications

The publication portfolio comprises peer-reviewed scholarly articles indexed within internationally recognized academic databases. These publications contribute to the dissemination of scientific findings and support knowledge exchange among researchers, practitioners, and policy stakeholders. Consistent publication activity demonstrates a commitment to rigorous scientific investigation and scholarly communication.[1]

Research Impact

Research impact can be assessed through citation indicators, publication visibility, and scholarly influence. With 1,376 citations generated across 1,259 citing documents and an h-index of 22, the available metrics indicate meaningful engagement by the scientific community. Such indicators suggest that the research outputs have contributed to ongoing academic discussions and informed subsequent investigations within relevant fields.[1][4]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and demonstrated contributions to medicine and health sciences, Raffaelina Mercogliano presents a profile consistent with the objectives of the Innovative Research Award. The combination of scholarly productivity and measurable research influence supports recognition within international academic award frameworks designed to celebrate excellence and innovation in research.[2]

Conclusion

The scholarly record of Raffaelina Mercogliano reflects sustained academic engagement, recognized research output, and measurable citation influence. Through contributions to medicine and health sciences, the researcher has established a profile characterized by scientific relevance and professional accomplishment. These attributes provide a strong foundation for recognition through the Innovative Research Award and related international research excellence programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Raffaelina Mercogliano, Author ID 24830941800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24830941800
  2. ORCID. (n.d.). ORCID record for Raffaelina Mercogliano.
    https://orcid.org/0000-0001-9167-4091
  3. Mercogliano, R., et al. (2003). Scientific research in food safety and public health. DOI:
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. DOI:
    https://doi.org/10.1073/pnas.0507655102
  5. World Health Organization. (n.d.). Health research and evidence-informed policy resources.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479